Drawing for GENOSCORE

USPTO serial 79350679

GENOSCORE

Reviewed by CopyMark Law Group

Reg. 7307296Status 700Registered
Filing date
Status date
Registration date
Feb 20, 2024
Examiner
HUSSAIN, TASNEEM
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENOSCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sean D. Detweiler

Sean D. Detweiler Morse, Barnes-Brown & Pendleton, P.C.480 Totten Pond Road, 4th FloorCityPointWaltham, MA 02451

Goods and services

ClassDescriptionStatusFirst use
042Software as a service services featuring software for use in early diagnosis of degenerative diseases; advisory services relating to genetic science; analysis of human tissues for medical research; biochemical research, development and analysis; biological research, development and analysis; biotechnological research, development and analysis; chemical research and analysis; clinical research in the field of degenerative diseases; consultancy relating to laboratory genetic testing for research purposes; laboratory research in the field of degenerative diseases; medical laboratory services; medical research; providing temporary use of non-downloadable computer software for accessing and using a cloud computing network; providing temporary use of web-based non-downloadable software for use in early diagnosis of degenerative diseases; providing temporary use of non-downloadable computer software; research and development services in the field of gene expression systems; providing temporary use of online non-downloadable computer software to aid early diagnosis of degenerative diseases; providing temporary use of online non-downloadable computer software to aid early diagnosis of progressive diseases; software as a service to aid early diagnosis of degenerative diseases; software as a service services featuring software to aid early diagnosis of progressive diseases; scientific risk assessment, namely, reviewing scientific data and studies and prediction and assessment of human health risks in the field of degenerative diseasesACTIVE—
044Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical treatment services; cognitive therapy services; cognitive and psychological examination and testing services; information, advice and consultancy in relation to all the aforesaid services; all the aforesaid being in the fields of dementia and cognitive declineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 9, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 9, 2024FIMPFINAL DISPOSITION PROCESSED—
May 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2023GPNXNOTIFICATION PROCESSED BY IB—
Nov 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 30, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2023RFNTREFUSAL PROCESSED BY IB—
Apr 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 25, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 3, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2023DOCKASSIGNED TO EXAMINER—
Sep 30, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance